vertigo from semaglutide The Risk of Vestibular Disorders with and Tirzepatide: Findings a Large Real-World Cohort Does GLP-1 Make You Dizzy?

The glucagon component enhances hepatic function, the GLP-1 component reduces systemic inflammation, and the GIP component improves metabolic signaling broadly

The weight loss effects observed with these medications result from both delayed gastric emptying and direct effects on appetite centers in the hypothalamus, leading to reduced hunger and increased satiety

Boyer, Nicholas J

Semaglutide is a GLP-1 receptor agonist that helps people lose weight by: The main difference between oral and injectable semaglutide is how it enters the body, not what it does once its there

Mod GRF(1-29) and GH dynamics

The CDC's diabetes research hub provides helpful context on how insulin dysregulation intersects with obesity and body composition, underscoring why this pathway must often be addressed before meaningful fat loss can occur